Antimicrobial Effectiveness of Locacorten-Vioform® Cream in Secondary Infections of Common Dermatoses

Abstract
In a double-blind study involving 430 patients, Locacorten (0.02%)-Vioform® (3%) cream was found to be highly effective in the treatment of dermatological conditions complicated by secondary bacterial involvement. The microbiological conversion and clinical improvement in patients treated with Locacorten-Vioform combinations were markedly greater than those achieved in the groups medicated with (1) Vioform 3%, (2) Locacorten 0.02%, and (3) placebo cream. Staphylococcus aureus was the most prevalent organism isolated from the skin lesions. All strains were sensitive to Vioform, as compared to 62% found to be resistant to other antimicrobials.

This publication has 1 reference indexed in Scilit: